Insufficient scRNA-seq data for expression of SERPINA4 at single-cell level.
Insufficient scRNA-seq data for expression of SERPINA4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 10149.73 | 226 / 226 | 95% | 280.42 | 387 / 406 |
| pancreas | 100% | 5663.77 | 328 / 328 | 84% | 67.81 | 149 / 178 |
| stomach | 75% | 1086.93 | 271 / 359 | 38% | 12.86 | 108 / 286 |
| kidney | 82% | 219.72 | 73 / 89 | 8% | 1.99 | 73 / 901 |
| esophagus | 1% | 1.77 | 9 / 1445 | 28% | 7.12 | 51 / 183 |
| intestine | 1% | 3.00 | 11 / 966 | 23% | 10.45 | 119 / 527 |
| lung | 0% | 0.54 | 1 / 578 | 13% | 4.40 | 155 / 1155 |
| prostate | 2% | 5.61 | 5 / 245 | 8% | 1.98 | 42 / 502 |
| uterus | 1% | 0.52 | 1 / 170 | 8% | 3.45 | 35 / 459 |
| bladder | 0% | 0 | 0 / 21 | 5% | 0.97 | 25 / 504 |
| breast | 1% | 3.58 | 3 / 459 | 1% | 0.14 | 16 / 1118 |
| ovary | 0% | 0 | 0 / 180 | 2% | 0.39 | 8 / 430 |
| peripheral blood | 1% | 2.70 | 7 / 929 | 0% | 0 | 0 / 0 |
| adipose | 1% | 3.32 | 8 / 1204 | 0% | 0 | 0 / 0 |
| skin | 0% | 0.23 | 4 / 1809 | 0% | 0.03 | 2 / 472 |
| adrenal gland | 0% | 0 | 0 / 258 | 0% | 0.23 | 1 / 230 |
| spleen | 0% | 5.53 | 1 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 1.02 | 2 / 1335 | 0% | 0 | 0 / 0 |
| heart | 0% | 0.36 | 1 / 861 | 0% | 0 | 0 / 0 |
| brain | 0% | 0.06 | 1 / 2642 | 0% | 0 | 0 / 705 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| thymus | 0% | 0 | 0 / 653 | 0% | 0 | 0 / 605 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0010951 | Biological process | negative regulation of endopeptidase activity |
| GO_0005615 | Cellular component | extracellular space |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0031089 | Cellular component | platelet dense granule lumen |
| GO_0005576 | Cellular component | extracellular region |
| GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
| Gene name | SERPINA4 |
| Protein name | Kallistatin (Kallikrein inhibitor) (Peptidase inhibitor 4) (PI-4) (Serpin A4) Serpin peptidase inhibitor, clade A (Alpha-1 antiproteinase, antitrypsin), member 4, isoform CRA_a (Testicular secretory protein Li 22) |
| Synonyms | PI4 hCG_22333 KST |
| Description | FUNCTION: Inhibits human amidolytic and kininogenase activities of tissue kallikrein. Inhibition is achieved by formation of an equimolar, heat- and SDS-stable complex between the inhibitor and the enzyme, and generation of a small C-terminal fragment of the inhibitor due to cleavage at the reactive site by tissue kallikrein. . |
| Accessions | P29622 ENST00000298841.5 ENST00000555095.5 A0A024R6I9 ENST00000557004.6 |